- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05458141
The Study Estimates the Longitudinal Impact of a Gamified Health Education App on Students' Health and Learning Outcomes (DVx-SCHOOL)
DVx - SCHOOL: Digital Vaccine for Scalable Curricular Health Outcome Optimization and Learning
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A 2-arm cluster randomized controlled trial with pre-, during- and post-treatment measurements will be conducted in a school in Chennai (India) - Panchayat Union Middle School (PUMS), Katchipedu - to assess and quantify the longitudinal impact of a proposed Digital Vaccine candidate, called FYA-003®, on students' knowledge, behaviors and outcomes related to diet, physical activity and health hygiene. After following the protocol for recruitment and informed consent, the investigators will pair up grades in the school (site) in consecutive order, such as grades 1-2, 3-4, 5-6, and 7-8, and randomly assign one grade in the pair to Group 1 and the other to Group 2. These pairs are assumed to be close to each other in age, maturity levels, health related knowledge, and exposure to mobile apps, hence appropriate for pairing up for the study.
A team of research staff located in Chennai will coordinate the execution of the experiment. After following the protocol for participation by the school administrator and staff, and the protocol for student recruitment and informed consent, the investigators will adopt a cluster-randomized trial design, where treatment assignment will be done at the grade level. Actual food choice, clinical measurements, survey data, and food logs will be collected by the site PI with support from a research project coordinator during weekly visits to the school. Game play data will be collected automatically whenever the mobile device is connected to the internet and will be downloaded to a secure server after the school visits. The research team will coordinate the gameplay timing with the school officials.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tamil Nadu
-
Kānchipuram, Tamil Nadu, India, 602105
- Panchayat Union Middle School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 5-14
- Parents willing to participate (fill out parent surveys)
Exclusion Criteria:
- Children physically unable to use a device
- Children with special needs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: Usual Education + Weekly Exposure to FYA-003
Students in grades assigned to Group 1 play FYA-003 in the classroom for 30 minutes every week for 12 weeks on a day at a time determined by the school & research team.
|
FYA-003: It is a gamified health education module for children aimed at promoting healthy nutrition, physical activity, health hygiene, and infectious diseases risk reduction within the clinically proven app fooya!
|
|
No Intervention: Group 2: Usual Education + Weekly exposure to non-health related educational mobile games
Students in grades assigned to Group 2 play educational games unrelated to health in the classroom for 30 minutes every week for 12 weeks on a day at a time determined by the school & research team.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health Knowledge Score - Baseline
Time Frame: Baseline
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
Baseline
|
|
Health Knowledge Score - Week 4
Time Frame: Week 4
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
Week 4
|
|
Health Knowledge Score - Week 8
Time Frame: Week 8
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
Week 8
|
|
Health Knowledge Score - Week 12
Time Frame: Week 12
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
Week 12
|
|
Health Knowledge Score - Week 12 + 3mo
Time Frame: 3 months after Week 12
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
3 months after Week 12
|
|
Health Knowledge Score - Week 12 + 6mo
Time Frame: 6 months after Week 12
|
Our primary outcome of interest is the health knowledge score, calculated based on students' survey responses to questions testing their knowledge on health hygiene, physical activity, and nutrition.
This will be measured as a percentage.
Higher percentages indicate a better outcome.
|
6 months after Week 12
|
|
Healthy Food Choice Score - Baseline
Time Frame: Baseline
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
Baseline
|
|
Healthy Food Choice Score - Week 4
Time Frame: Week 4
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
Week 4
|
|
Healthy Food Choice Score - Week 8
Time Frame: Week 8
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
Week 8
|
|
Healthy Food Choice Score - Week 12
Time Frame: Week 12
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
Week 12
|
|
Healthy Food Choice Score - Week 12 + 3mo
Time Frame: 3 months after Week 12
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
3 months after Week 12
|
|
Healthy Food Choice Score - Week 12 + 6mo
Time Frame: 6 months after Week 12
|
Observed "Good Food" choice indicator, as measured based on actual food choices by participants.
This is a binary 0-1 value. 1 indicates a better outcome.
|
6 months after Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical biomarkers: BMI Baseline
Time Frame: Baseline
|
Body Mass Index of participants
|
Baseline
|
|
Clinical biomarkers: BMI Week 12
Time Frame: Week 12
|
Body Mass Index of participants
|
Week 12
|
|
Clinical biomarkers: BMI Week 12 + 3mo
Time Frame: 3 months after Week 12
|
Body Mass Index of participants
|
3 months after Week 12
|
|
Clinical biomarkers: BMI Week 12 + 6mo
Time Frame: 6 months after Week 12
|
Body Mass Index of participants
|
6 months after Week 12
|
|
Clinical biomarkers: Average Temperature
Time Frame: Captured every week (Week 1 - Week 12)
|
Average temperature of participants captured every weekly visit
|
Captured every week (Week 1 - Week 12)
|
|
Food Log Health Score - Baseline
Time Frame: Baseline
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
Baseline
|
|
Food Log Health Score - Week 4
Time Frame: Week 4
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 4
|
|
Food Log Health Score - Week 8
Time Frame: Week 8
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 8
|
|
Food Log Health Score - Week 12
Time Frame: Week 8, Week 12, 3 months after Week 12, 6 months after Week 12
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 8, Week 12, 3 months after Week 12, 6 months after Week 12
|
|
Food Log Health Score - Week 12 + 3mo
Time Frame: 3 months after Week 12
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
3 months after Week 12
|
|
Food Log Health Score - Week 12 + 6mo
Time Frame: 6 months after Week 12
|
Proportion of "Healthy" food items consumed in the weekly food logs recorded by the participants.
Scale of 0 to 100.
Higher score means better outcomes.
|
6 months after Week 12
|
|
Healthy Lifestyle Score - Baseline
Time Frame: Baseline
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
Baseline
|
|
Healthy Lifestyle Score - Week 4
Time Frame: Week 4
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 4
|
|
Healthy Lifestyle Score - Week 8
Time Frame: Week 8
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 8
|
|
Healthy Lifestyle Score - Week 12
Time Frame: Week 12
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
Week 12
|
|
Healthy Lifestyle Score - Week 12 + 3mo
Time Frame: 3 months after Week 12
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
3 months after Week 12
|
|
Healthy Lifestyle Score - Week 12 + 6mo
Time Frame: 6 months after Week 12
|
Self-reported Weekly Healthy Lifestyle Score measured on the basis of participant survey responses to questions on physical activity, nutrition behavior, hygiene habits.
Scale of 0 to 100.
Higher score means better outcomes.
|
6 months after Week 12
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rema Padman, PhD, Carnegie Mellon University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VHS/IEC/143/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on FYA-003
-
Nanjing Leads Biolabs Co.,LtdHenan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and InstituteCompletedAdvanced Malignant TumorChina
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Enrolling by invitation
-
Wave Life Sciences Ltd.CompletedHuntington DiseaseSpain, Australia, Denmark, Canada, Netherlands, United Kingdom, Germany, France, Poland, Italy
-
Longbio PharmaNot yet recruitingChronic Rhinosinusitis With Nasal Polyps (CRSwNP)China
-
Shanghai Kechow Pharma, Inc.Recruiting
-
University of North Carolina, Chapel HillNaturex SACompleted
-
Huahui HealthCompletedChronic Hepatitis Delta Virus InfectionChina
-
Longbio PharmaCompletedSeasonal Allergic RhinitisChina
-
StemcentrxTerminatedOvarian CancerUnited States
-
Longbio PharmaCompletedChronic Spontaneous UrticariaChina